Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States

[Image: see text] Mutations to RAS proteins (H-, N-, and K-RAS) are among the most common oncogenic drivers, and tumors harboring these lesions are some of the most difficult to treat. Although covalent small molecules against KRAS(G12C) have shown promising efficacy against lung cancers, traditiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Shuhui, Khoo, Regina, Juang, Yu-Chi, Gopal, Pooja, Zhang, Huibin, Yeo, Constance, Peh, Khong Ming, Teo, Jinkai, Ng, Simon, Henry, Brian, Partridge, Anthony W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908030/
https://www.ncbi.nlm.nih.gov/pubmed/33655066
http://dx.doi.org/10.1021/acscentsci.0c01337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908030/
https://www.ncbi.nlm.nih.gov/pubmed/33655066
http://dx.doi.org/10.1021/acscentsci.0c01337

Ejemplares similares